Frederic Regenstein
Impact in
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Hepatology top 5%
- Liver physiology and pathology
- Liver Diseases and Immunity
- Hepatitis C virus research
Papers in
-
- Hepatitis C virus research 2
-
- Hepatitis B Virus Studies 2
- Liver Disease Diagnosis and Treatment 1
- Co-authors
- Mark Robert Wick (1 shared paper)Caroline A. Riely (1 shared paper)Carolyn R. Campbell (1 shared paper)Robert P. Perrillo (1 shared paper)Vincent G. Bain (1 shared paper)Kent G. Benner (1 shared paper)Randall G. Lee (1 shared paper)Andrew L. Mason (1 shared paper)
- Journals
- Gastroenterology (2 papers)The Lancet (1 paper)Hepatology Communications (1 paper)PubMed (4 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Frederic Regenstein
8 papers receiving 1.2k citations
Frederic Regenstein's Hit Papers
Peers
Comparison fields: 5 of 57
- Epidemiology 855
- Hepatology 170
- Oncology 122
- Pharmacology 31
- Molecular Biology 144
Countries citing papers authored by Frederic Regenstein
This map shows the geographic impact of Frederic Regenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Regenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Regenstein more than expected).
Fields of papers citing papers by Frederic Regenstein
This network shows the impact of papers produced by Frederic Regenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Regenstein. The network helps show where Frederic Regenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederic Regenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1078 |
| 2 | 1993 | 60 | |
| 3 | Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity. | 1993 | 26 |
| 4 | Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. | 1996 | 21 |
| 5 | 2017 | 20 | |
| 6 | Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. | 1997 | 15 |
| 7 | Successful liver/kidney transplantation across ABO incompatibility. | 1993 | 3 |
| 8 | 2001 | 2 |
About Frederic Regenstein
Frederic Regenstein is a scholar working on Hepatology, Epidemiology, Transplantation, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (2 papers), Hepatitis B Virus Studies (2 papers), Renal Transplantation Outcomes and Treatments (1 paper), Heart Rate Variability and Autonomic Control (1 paper), Liver Disease Diagnosis and Treatment (1 paper), Organ Transplantation Techniques and Outcomes (1 paper), Transplantation: Methods and Outcomes (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Epidemiology (855 citations), Hepatology (170 citations), Oncology (122 citations), Pharmacology (31 citations) and Molecular Biology (144 citations). Frederic Regenstein has collaborated with scholars based in United States and Canada. Frequent co-authors include Mark Robert Wick, Caroline A. Riely, Carolyn R. Campbell, Robert P. Perrillo, Vincent G. Bain, Kent G. Benner, Randall G. Lee, Andrew L. Mason, JOHN L. HUSSEY and Louis Balart. Their work appears in journals such as Gastroenterology, The Lancet, Hepatology Communications and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.